一条通过的生命线:新生儿完整的心脏阻塞未经纠正的证据中的紧急步调
Abdul Malik Sheikh1, Taliah Naseer Tarar2, Hina Sattar3
1Department of Pediatric Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan.
概括
新生儿的完整先天性心脏阻塞 (CHB) 是一个危急的情况. 当传统方法在早产婴儿中失败时,脉通道提供了一种拯救生命的临时节奏解决方案.
科学领域:
- 新生儿心脏病学 新生儿心脏病学
- 儿科电子生理学 儿科电子生理学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 完整的先天性心房阻塞 (CHB) 是一种罕见的,危及生命的新生儿疾病.
- 经常与母亲自身免疫连接组织疾病有关,CHB需要迅速管理.
- 在早产婴儿的血管访问节奏可以在技术上具有挑战性.
研究的目的:
- 突出成功使用静脉接入用于CHB过早新生儿的暂时透静脉激活.
- 在具有挑战性的新生儿病例中,将静脉作为紧急血管接入的可行替代方案.
主要方法:
- 一个早产新生儿 (35+1周) 患有先天性第三级心脏阻塞的病例报告.
- 在失败的股骨通道后,通过脉进行紧急临时的静脉穿越节奏.
- 成功地将永久心脏起器植入到永久心脏起器植入.
主要成果:
- 静脉提供了一个快速的,床边的,不那么侵入性的血管接入路线.
- 通过静脉成功实现了紧急临时节奏.
- 新生儿得到了稳定,并与永久的心脏起器植入桥梁.
结论:
- 静脉通道是一种有价值和有效的替代方案,用于在常规途径失败时,在早产新生儿的紧急节奏.
- 这种方法可以在CHB引起的血液动力学损害的情况下拯救生命.
- 顺利通过脉进行临时节奏调节可以促进进一步的治疗,并改善CHB新生儿的治疗结果.
相关概念视频
Dysrhythmias IV: Characteristics of Bradyarrhythmias
717
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
717
Disturbances in Heart Rhythm
3.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Electrophysiology of Normal Cardiac Rhythm
10.0K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
10.0K
Cardiac Action Potential
8.0K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
8.0K
Dysrhythmias VI: Management of Dysrhythmias
554
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
554


